Home

cart Raincoat Resignation glaxo market cap Thank you for your help Engaged carbon

GSK spinoff starts trading at LSE - what you need to know
GSK spinoff starts trading at LSE - what you need to know

GSK (GSK) Stock Price, News & Info | The Motley Fool
GSK (GSK) Stock Price, News & Info | The Motley Fool

GSK lines up Rs 6,400cr open offer - Times of India
GSK lines up Rs 6,400cr open offer - Times of India

UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction -  Bloomberg
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg

Taking A Look At The Special Situation With GlaxoSmithKline (NYSE:GSK) |  Seeking Alpha
Taking A Look At The Special Situation With GlaxoSmithKline (NYSE:GSK) | Seeking Alpha

Better Buy: GlaxoSmithKline vs. Eli Lilly | The Motley Fool
Better Buy: GlaxoSmithKline vs. Eli Lilly | The Motley Fool

Glaxo Underperforms Industry in a Year: What's in Store?
Glaxo Underperforms Industry in a Year: What's in Store?

4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio
4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio

GSK Stock Price and Chart — LSE:GSK — TradingView
GSK Stock Price and Chart — LSE:GSK — TradingView

GlaxoSmithKline Pharmaceuticals Share: Motilal Oswal Financial Services  neutral on GlaxoSmithKline Pharmaceuticals; target price: Rs 1300 - The  Economic Times
GlaxoSmithKline Pharmaceuticals Share: Motilal Oswal Financial Services neutral on GlaxoSmithKline Pharmaceuticals; target price: Rs 1300 - The Economic Times

Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?
Glaxo (GSK) to Report Q1 Earnings: What's in the Cards?

GlaxoSmithKline: Back To The Drawing Board (NYSE:GSK) | Seeking Alpha
GlaxoSmithKline: Back To The Drawing Board (NYSE:GSK) | Seeking Alpha

GSK spins off Haleon in biggest European listing for a decade
GSK spins off Haleon in biggest European listing for a decade

Better Buy: Eli Lilly vs. GlaxoSmithKline | The Motley Fool
Better Buy: Eli Lilly vs. GlaxoSmithKline | The Motley Fool

Elliott Publishes Letter on GlaxoSmithKline
Elliott Publishes Letter on GlaxoSmithKline

Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide
Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide

GSK falls victim to 'hard to please' pharma market | LSE:GSK, NYSE:GSK
GSK falls victim to 'hard to please' pharma market | LSE:GSK, NYSE:GSK

GSK Stock Price and Chart — LSE:GSK — TradingView
GSK Stock Price and Chart — LSE:GSK — TradingView

Glaxo (GSK) Q4 Earnings Lag Estimates, Shingrix Back on Track
Glaxo (GSK) Q4 Earnings Lag Estimates, Shingrix Back on Track

Elliott Publishes Letter on GlaxoSmithKline
Elliott Publishes Letter on GlaxoSmithKline

Glaxo (GSK) to Report Q4 Earnings: What's in the Cards?
Glaxo (GSK) to Report Q4 Earnings: What's in the Cards?

London stock market listing of up to £45bn looms as GSK investors vote for  demerger | GlaxoSmithKline | The Guardian
London stock market listing of up to £45bn looms as GSK investors vote for demerger | GlaxoSmithKline | The Guardian

Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide
Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide

Investors in GSK (LON:GSK) have unfortunately lost 8.3% over the last three  years - Simply Wall St News
Investors in GSK (LON:GSK) have unfortunately lost 8.3% over the last three years - Simply Wall St News